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Normal somatic cells have a limited capacity for 
division in culture and eventually enter a state of 
terminal growth arrest termed replicative senescence 
[1]. Cells that fail to undergo senescence divide 
indefinitely and develop chromosomal aberrations 
resulting in neoplastic transformation. Senescence is 
believed to be a tumor suppressor mechanism that 
ensures that cells permanently exit the cell cycle, 
rendering them incapable of forming a tumor. Senescent 
cells do not divide in response to mitogen stimulation, 
but remain metabolically active and show characteristic 
changes in cellular morphology. Senescent cells also 
display specific biochemical properties, such as the 
expression of a β-galactosidase activity at pH 6 (SA-β-
gal) that has long been used as a senescence marker. 
Senescent cells accumulate as the organism ages and 
thus the number of SA-β-gal-positive cells increases in 
older individuals and in individuals with premature 
aging syndromes. It is well established that senescence 
is associated with perturbations in gene expression 
profiles, including increased levels of cell cycle 
inhibitors such as p16INK4A and p53, and decreased  
levels of E2F target genes, and the RNA-binding 
protein HuR. 
 
 MicroRNAs (miRNAs) are a major class of regulatory 
molecules that inhibit gene expression post-
transcriptionally by binding to target mRNAs to 
promote their degradation and/or inhibit their 
translation. They have been shown to regulate several 
processes including cellular proliferation, differentiation 
and apoptosis. miRNAs are deregulated in cancer and 
can function as tumor suppressors or oncogenes. Given 
the link between cancer and senescence, it is not 
surprising that miRNAs  that  regulate  senescence  have  
 
 
                                                        Commentary  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
begun to be identified. In fact, global loss of miRNAs 
has been shown to induce senescence in primary cells 
[2], suggesting that the miRNA pathway prevents the 
cells from undergoing senescence. In a physiological 
context in which normal cells divide and undergo 
senescence, it is plausible that senescence is achieved 
by the combined down-regulation of some miRNAs that 
inhibit senescence and up-regulation of select miRNAs 
that promote the senescence program. Identifying these 
senescence-associated miRNAs is therefore essential to 
understand their roles in senescence and cancer.  
 
In this issue of AGING, Marasa et al., used a highly 
sensitive genome-wide approach to identify miRNAs 
that are differentially expressed during replicative 
senescence of normal human diploid fibroblasts (WI-38 
cells). They found that the expression of several 
miRNAs was altered during senescence, including miR-
519, which the authors had previously shown to inhibit 
the translation of the RNA-binding protein HuR by 
base-pairing to the coding region of HuR mRNA [3]. 
Overexpression of miR-519 in early-passage WI-38 
cells altered the expression of some senescence-
associated proteins: SIRT1 and HuR were down-
regulated, whereas p53 and p16INK4A were up-
regulated. Down-regulation of HuR in these cells, likely 
a consequence of base-pairing between miR-519 and 
HuR mRNA, in turn led to decreased levels of the HuR 
target SIRT1 mRNA and decreased SIRT1 protein [4]. 
On the other hand, increased expression of p53 and 
p16INK4A would likely be an indirect effect of miR-
519 overexpression. These changes in gene expression 
should be sufficient to induce cellular senescence. 
Indeed, the authors showed that sustained over-
expression of miR-519 in early-passage WI-38 cells 
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induction of senescence. This effect also extended to the 
highly proliferative and transformed HeLa cells, in 
which overexpression of miR-519 similarly triggered a 
senescent phenotype. Given the negative correlation 
between the abundance of miR-519 and HuR in normal 
versus tumor tissue and the previous finding that miR-
519 reduced tumorigenesis [5], the authors hypothesize 
that miR-519 represses tumor growth by promoting 
senescence. They further propose that this effect of 
miR-519 is partly mediated by down-modulating HuR 
levels.  
miRNAs typically down-regulate the expression of 
hundreds of genes. Although HuR appears to be an 
important target of miR-519, miR-519 may also lower 
the expression of many other genes. Recent studies have 
shown that mRNA degradation is the major mechanism 
by which mammalian miRNAs inhibit target gene 
expression [6]. Therefore, over-expressing miR-519 in 
early-passage WI-38 cells followed by microarray or 
proteomic analysis will identify many transcripts 
directly regulated by miR-519. Alternatively, the 
recently developed Argonaute HITS-CLIP approach [7] 
could identify cellular transcripts that directly bind to 
miR-519  in vivo. Combining the gene lists generated 
from these experimental strategies with Gene Ontology 
and gene network analysis [8] will further elucidate the 
role of miR-519 in senescence and tumorigenesis. 
 
The Marasa et al. report identifies an important 
mechanism by which miR-519 could inhibit 
tumorigenesis. By down-regulating HuR protein levels, 
miR-519 would decrease the expression of HuR target 
genes (such as SIRT1), many of which promote 
proliferation, invasion and angiogenesis. The findings 
by Marasa et al., may also have important implications 
for cancer therapy. Traditional therapies aim to halt 
cancer by inducing cell differentiation, promoting cell 
death, or reducing proliferation. By identifying miRNAs 
associated with replicative senescence, we can envision 
treatments to induce senescence in tumor cells. miRNA-
based therapies are particularly promising because a 
single miRNA can modulate the expression of 
numerous genes working in coordination to shut down a 
biological process. The challenge of specifically 
delivering the miRNA to tumor cells remains; however, 
since miRNAs are chemically similar to siRNAs, 
delivery methods could be employed similar to those 
currently used for siRNA in mouse models of cancer.  
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Several important questions remain open for further 
study. First, is up-regulation of miR-519 essential for 
cells to undergo senescence? If it is, then stable 
knockdown of miR-519 in early-passage WI-38 cells 
should prevent senescence. Second, is miR-519-
mediated regulation of HuR important during 
senescence? Rescue experiments employing an 
engineered miR-519-insensitive HuR will answer this 
question. Third, since miR-519 is poorly conserved, 
what is the evolutionary significance of miR-519-
mediated regulation of HuR? Fourth, what mechanisms 
control the increased expression of miR-519 during 
senescence? A detailed analysis of the miR-519 gene 
promoter will help to identify putative transcription 
factors capable of regulating miR-519 expression during 
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